Ireland· IE-PA-PA2242/017/001
Pabrinex Intravenous High Potency Concentrate for Solution for Infusion
A vitamin b-complex with vitamin c product containing ascorbic acid + riboflavin + pyridoxine hydrochloride + nicotinamide, registered in Ireland by Grunenthal Pharma Limited.. The same ATC class is registered in 4 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Ascorbic acid + riboflavin + pyridoxine hydrochloride + nicotinamide is registered in 4 of 19 countries.
Countries holding a registration under ATC A11EB (vitamin b-complex with vitamin c), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 2 of them publish a price we can compare per daily dose
Ascorbic acid + riboflavin + pyridoxine hydrochloride + nicotinamide · ATC A11EB
4 / 19 countries
- Denmark
- Finlandprice
- Ireland
- Norwayprice
The record
At a glance
HPRA (Ireland)- Active substance
- Ascorbic acid + Riboflavin + Pyridoxine hydrochloride + Nicotinamide
- Manufacturer
- Grunenthal Pharma Limited.
- Country
- Ireland (IE)
- ATC code
- A11EB
- ATC class
- Vitamin B-complex with vitamin C
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA2242/017/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A11EB
Vitamin b-complex with vitamin c, as other registers publish it.
- FinlandAllbee + CJohn Wyeth & Brother Ltd
- FinlandAllbee CA.H. Robins Company Limited
- NorwayCibivinNoridem Enterprises Ltd.
- NorwayPabrinex IM high potencyKyowa Kirin Limited
- IrelandVitamins B and C concentrate for solution for infusionNoridem Enterprises Limited
- DenmarkZubatminMacure Pharma ApS
- FinlandZubatminMacure Pharma ApS
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fd219bb9-cdb3-4785-a2b0-2546652fcc8a GET /v1/drugs/fd219bb9-cdb3-4785-a2b0-2546652fcc8a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Concentrate for solution for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"A11EB"
],
"strength": null,
"pa_number": "PA2242/017/001",
"substances": [
"Ascorbic acid",
"Riboflavin",
"Pyridoxine hydrochloride",
"Nicotinamide",
"Thiamine hydrochloride",
"Glucose (as monohydrate)"
],
"legal_basis": "Informed consent application (Article 10c of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "20/08/1987",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about ascorbic acid + riboflavin + pyridoxine hydrochloride + nicotinamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.